8:15am ET
Health and Healthcare
Short Sellers Take Mixed Stance on Major Pharma
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Companies
/Healthcare
Pfizer Inc
$28.32
▼ $0.25 (−0.88%) today
Markets closed · 6:15pm ET
PFE Coverage
Page 546:10am ET
Investing
The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite
However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of the month.
10:20am ET
Health and Healthcare
8 Stocks on the Move After ASCO Cancer Abstracts
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these…
7:50am ET
Health and Healthcare
Pfizer Pays $5.2 Billion for Anacor
Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more than $5 billion.
7:40am ET
Health and Healthcare
ASCO Could Make or Break These 7 Cancer Drug Trials
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to…
8:45am ET
Health and Healthcare
Major Pharma Short Interest Continues to Recede
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
6:20am ET
Investing
The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat
As the markets reached all-time highs last month, the short sellers were in retreat, judging by the moves in the most heavily shorted stocks traded on the New York Stock Exchange.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer and SolarCity.
10:05am ET
Investing
4 Top Blue Chip Dividend Stocks to Buy and Hold Forever
These stocks should do well for years regardless of who the next president is. They all have incredible franchises, long and mature product silos and, importantly, very strong consumer brand awareness.
12:30pm ET
Health and Healthcare
Analysts Adjust Predictions on Medivation Buyout Price
One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation found itself in.
7:35am ET
Health and Healthcare
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates…
4:01pm ET
Investing
The 5 Dow Stocks That Defied the Selling Tuesday
May 3, 2016: Markets opened lower Tuesday following some overnight weakness in overseas markets resulting from weak data on trade from both China and Europe and a strengthening dollar. Energy prices were…
7:25am ET
Health and Healthcare
Pfizer Boosts Guidance With Help From Hospira, Weaker Dollar
Pfizer reported better-than-expected first-quarter 2016 results before markets opened Tuesday morning.
Paul Ausick 12:15pm ET
Health and Healthcare
What to Expect From Pfizer Earnings
Pfizer is scheduled to report its first-quarter financial results before the markets open on Tuesday.
Chris Lange 9:15am ET
Investing
Top 6 Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and some of the other major companies reporting their quarterly results this week.